Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The expression ratio of Map7/B2M is prognostic for survival in patients with stage II colon cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The expression ratio of Map7/B2M is prognostic for survival in patients with stage II colon cancer.
The expression ratio of Map7/B2M is prognostic for survival in patients with stage II colon cancer. Int J Oncol. 2008 Sep; 33(3):579-84.
View in:
PubMed
subject areas
Adenocarcinoma
Aged
Aged, 80 and over
Area Under Curve
beta 2-Microglobulin
Biomarkers, Tumor
Colonic Neoplasms
Female
Gene Expression
Humans
Kaplan-Meier Estimate
Male
Microtubule-Associated Proteins
Neoplasm Staging
Prognosis
Reverse Transcriptase Polymerase Chain Reaction
ROC Curve
authors with profiles
David J. Cole
Elizabeth Garrett Garrett-Mayer